2023
DOI: 10.1101/2023.02.11.528123
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Changes in social behaviour with alterations of MAPK3 and KCTD13/CUL3 pathways in two new outbred rat models for the 16p11.2 syndromes with autism spectrum disorders

Abstract: Copy number variations (CNVs) of the human 16p11.2 locus are associated with several developmental/neurocognitive syndromes. Particularly, deletion and duplication of this genetic interval are found in patients with autism spectrum disorders, intellectual disability and other psychiatric traits. The high gene density associated with the region and the strong phenotypic variability of incomplete penetrance, make the study of the 16p11.2 syndromes extremely complex. To systematically study the effect of 16p11.2 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 52 publications
0
4
0
Order By: Relevance
“…Similarly, in the social domain, the contribution of each gene within the deleted region could also be detailed, as it has been done to identify the contribution of Kctd13 gene to the cognitive impairment phenotype (Arbogast et al, 2019;Martin Lorenzo et al, 2021). To ascertain the robustness of these findings, a cross-species comparison should be conducted in the rat model (Martin Lorenzo et al, 2023), as recommended in recent guidelines to increase the value and robustness of preclinical models (Silverman et al, 2022). Rescue strategies could then be attempted, with for instance R-baclofen, a GABAb agonist, or Fasudil, an inhibitor of the Rho-associated protein kinase, both restoring the cognitive deficits in the mouse model (Stoppel et al, 2018;Martin Lorenzo et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in the social domain, the contribution of each gene within the deleted region could also be detailed, as it has been done to identify the contribution of Kctd13 gene to the cognitive impairment phenotype (Arbogast et al, 2019;Martin Lorenzo et al, 2021). To ascertain the robustness of these findings, a cross-species comparison should be conducted in the rat model (Martin Lorenzo et al, 2023), as recommended in recent guidelines to increase the value and robustness of preclinical models (Silverman et al, 2022). Rescue strategies could then be attempted, with for instance R-baclofen, a GABAb agonist, or Fasudil, an inhibitor of the Rho-associated protein kinase, both restoring the cognitive deficits in the mouse model (Stoppel et al, 2018;Martin Lorenzo et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Rat models for 16p11.2 CNVs have also been generated recapitulating craniofacial phenotypes, with mirror effects between the DEL and the DUP conditions (Qiu et al, 2019). Converging and male-specific deficits in social behaviour and novel object recognition have been also observed in 16p11.2 DEL and DUP rats in two different genetic backgrounds (Martin Lorenzo et al, 2023). RNA sequencing analysis in the hippocampus found 267 differentially expressed genes dysregulated in DEL and DUP rat models.…”
Section: Other Animal Models 16p112 Del and Dup Rat Modelsmentioning
confidence: 92%
“…Frontiers in Pharmacology frontiersin.org 13 Differential functional analysis revealed 23 upregulated pathways in both DEL and DUP rats, associated with morphogenesis of the primary cilium. However, pathways related to synaptic function and metabolism were mostly deregulated in DEL rats, while pathways associated with transcription, epigenomic regulation and hormone regulation were mostly affected in DUP animals (Martin Lorenzo et al, 2023).…”
Section: Other Animal Models 16p112 Del and Dup Rat Modelsmentioning
confidence: 93%
“…In this same line, the contribution to the phenotype of each gene within the deleted region could also be detailed, as it has been done to identify the contribution of Kctd13 gene to the cognitive impairment phenotype (Arbogast et al, 2019;Martin Lorenzo et al, 2021). To ascertain the robustness of these findings, a cross-species comparison should be conducted in the rat model (Martin Lorenzo et al, 2023), as recommended in recent guidelines to increase the value and robustness of preclinical models (Silverman et al, 2022). Rescue strategies could then be attempted, with for instance R-baclofen, a GABAb agonist, or Fasudil, an inhibitor of the Rho-associated protein kinase, both restoring the cognitive deficits in the mouse model (Stoppel et al, 2018;Martin Lorenzo et al, 2021).…”
Section: Perspectivesmentioning
confidence: 99%